Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2017

Open Access 01-12-2017 | Research article

Chinese herbal Pulian ointment in treating psoriasis vulgaris of blood-heat syndrome: a multi-center, double-blind, randomized, placebo-controlled trial

Authors: Nuo Li, Wenbin Zhao, Jianmin Xing, Jianping Liu, Guangzhong Zhang, Yunbi Zhang, Yuanwen Li, Wali Liu, Fei Shi, Yanping Bai

Published in: BMC Complementary Medicine and Therapies | Issue 1/2017

Login to get access

Abstract

Background

Traditional Chinese medicine (TCM) has a long history in the treatment of psoriasis vulgaris. We aimed to evaluate the clinical efficacy and safety of Chinese herbal Pulian ointment in treating psoriasis vulgaris of blood-heat syndrome.

Methods

A multicenter, randomized, double-blind, placebo-controlled trial was conducted. Participants with psoriasis vulgaris of blood-heat syndrome were blinded and randomized to receive Pulian ointment or placebo ointment twice daily for 4 weeks, with follow-up 8 weeks after treatment. Psoriasis Area Severity Index (PASI) scores, severity of each symptom and area of skin lesion and quality of life were assessed at baseline, 2 weeks, and 4 weeks. Adverse events were recorded during the study. SAS 9.4 software and SPSS 17.0 software was applied for data analysis.

Results

A total of 300 participants with psoriasis vulgaris of blood-heat syndrome were assessed for eligibility, and 294 were randomly assigned to the Pulian ointment and placebo group from six study centers. Full analysis set (FAS): after 4 weeks of treatment, there were significant differences between groups in PASI score and the separate score of skin lesion area, favoring Pulian ointment group (P < 0.05). However, no significant differences were observed in scores of scaling, erythema and induration/thickness (P > 0.05). Per protocol set (PPS): There was no statistically significant difference in PASI score and separate score of each symptom and area of skin lesion between two groups (P > 0.05). Quality of life measured by Hamilton Anxiety Rating Scale (HAMA) and 36-Item Short Form Health Survey (SF-36) improved after treatment in both groups, but there was no significant difference between the two groups (P > 0.05). After being followed up for 8 weeks, the total relapse rates of the Pulian Ointment group and placebo group were 5.88 and 8.45%, respectively, and the difference was not statistically significant between the two groups (P > 0.05). No adverse event was observed in both groups throughout the study.

Conclusions

Pulian Ointment seems effective and well tolerated in improving the PASI score and separate score of skin lesion area for patients with psoriasis vulgaris of blood-heat syndrome. Further research could build on the current study to explore whether other preparation forms and greater intervention intensity are necessary for better therapeutic effects.

Trial registration

Chictr.org.cn Identifier ChiCTR-TRC-12002054.

Literature
  1. Perera GK, Di Meglio P, Nestle FO. Psoriasis. Annu Rev Pathol. 2012;7:385–422.View ArticlePubMed
  2. Ding XL, Wang TL, Shen YW, et al. Prevalence of Psoriasis in China: An Epidemiological Survey In Six Provinces. Chin J Dermatovenereology. 2010;07:598–601.
  3. Zhang LX, Yang DQ, Song PH, et al. Application of Pu Lian ointment in the treatment of psoriasis. J External Ther Tradit Chin Med. 2000;9(5):22–3.
  4. Xu J, Zhang C, Qu X, et al. Clinical and Experimental Study on Effect of Qinbai Ointment In Treating Psodasis in the Active Stage of Blood-Heat Syndrome Type. Chin J Integrated Tradit West Med. 2009;07:614–8.
  5. Zhang J, Liu HY, Yu XJ. Effects of baicalin on proliferation and expression of IL一8 in culture HaCaT keratinocytes. J Taishan Med Coll. 2006;04:326–7.
  6. Zhao B. Clinical Dermatology. 3rd ed. Nanjing: Jiangsu Science and Technology Press; 2001. p. 759–72.
  7. Zheng XY. Guiding principles for clinical research on new drug of traditional Chinese Medicine. 1st ed. Beijing: China Medical Science and Technology Press; 2002. p. 299–302.
  8. Pacifico A, Leone G. Evaluation of a skin protection cream for dry skin in participants undergoing narrow band UVB phototherapy for psoriasis vulgaris. G Ital Dermatol Venereol. 2011;146(3):179–83.PubMed
  9. Quan SW. Modern Research on Chemical Composition and Pharmacological Effects of Cortex Phellodendri. World Health Digest. 2014;26:185–6.
  10. Choi YY, Kim MH, Han JM, Hong J, Lee TH, Kim SH, Yang WM. The anti-inflammatory potential of Cortex Phellodendron in vivo and in vitro: down-regulation of NO and iNOS through suppression of NF-κB and MAPK activation. Int Immunopharmacol. 2014;19(2):214–20.View ArticlePubMed
  11. Chi GF, Ding L, Chang LM, et al. The Present Domestic Pharmacological Advance on Scutellaria Baicalensis. J Inner Mongolia Univ Nationalities (Natural Sciences). 2005;20(2):207–9.
  12. Mao ZY, Gao C, Ai HW. Effects of Rhubarb and Scutellaria Emulsion on Psoriasis Mice. J Hubei Univ Chin Med. 2013;15(1):21–2.
  13. Wu J, Liu X, Qiu ZJ, et al. Effects of Main Components of Scutellaria on Expression of CD69 of Jurkat T cell Induced by the PDB + Ion. Chin J Exp Tradit Med Formulae. 2010;16(9):188–90.
  14. Wang YN, Bi XL, Gu J, et al. Effects of Baicalin on Expression of Inducible Nitric Oxide Synthase in Cultured Fibroblasts. Chin J Dermatovenerology Integrated Tradit West Med. 2003;2(3):152–4.
  15. Yang W, Li H, Cong X, Wang X, Jiang Z, Zhang Q, Qi X, Gao S, Cao R, Tian W. Baicalin attenuates lipopolysaccharide induced inflammation and apoptosis of cow mammary epithelial cells by regulating NF-κB and HSP72. Int Immunopharmacol. 2016;40:139–45.View ArticlePubMed
  16. Wu J, Li H, Li M. Effects of baicalin cream in two mouse models: 2, 4- dinitrofluorobenzene-induced contact hypersensitivity and mouse tail test for psoriasis. Int J Clin Exp Med. 2015;8(2):2128–37.PubMedPubMed Central
Metadata
Title
Chinese herbal Pulian ointment in treating psoriasis vulgaris of blood-heat syndrome: a multi-center, double-blind, randomized, placebo-controlled trial
Authors
Nuo Li
Wenbin Zhao
Jianmin Xing
Jianping Liu
Guangzhong Zhang
Yunbi Zhang
Yuanwen Li
Wali Liu
Fei Shi
Yanping Bai
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2017
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-017-1631-5

Other articles of this Issue 1/2017

BMC Complementary Medicine and Therapies 1/2017 Go to the issue